Polaryx Therapeutics, Inc. (PLYX) Insider Trading -- Recent Executive & Director Transactions

1 insiders reported 1 Form 4 transactions for Polaryx Therapeutics, Inc. (PLYX) over the past 18 months (most recent 2026-02-20). Recent activity: Landis G. Michael (Chief Financial Officer) Buy 2,867 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-02-20Landis G. MichaelChief Financial OfficerBuy2,867$7,999

Source: SEC Form 4 filings · as of 2026-02-20